LASP1 served as a target of miR‐133a in regulating NSCLC development and miR‐133a achieved an inhibitory effect on NSCLC by suppressing TGF‐β/Smad3 signaling pathway. This evidence concerns the gene LASP1 and non-small cell lung carcinoma.